Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5823560 | 0.84 | — | — | |
| SCHEMBL2019930 | 0.83 | — | — | |
| SCHEMBL2754120 | 0.78 | — | — | |
| SCHEMBL15088217 | 0.76 | ALDH1A1 (0.33) | — | |
| SCHEMBL198636 | 0.74 | — | — | |
| SCHEMBL12144201 | 0.74 | — | — | |
| SCHEMBL4857662 | 0.72 | — | — | |
| SCHEMBL1013207 | 0.72 | PRKCA (0.35) | EPHX1 | |
| SCHEMBL2342176 | 0.71 | MAOA (0.37) | — | |
| SCHEMBL5730456 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11773212-B2 | Preparation method of polymer | LG ENERGY SOLUTION, LTD. (KR) | 2023-10-03 | — | — | US | disclosed |
| US-11773212-B2 | Preparation method of polymer | LG ENERGY SOLUTION, LTD. (KR) | 2023-10-03 | — | — | US | disclosed |
| US-20230307647-A1 | Electrode Active Material for Secondary Battery and Method of Manufacturing Same | LG ENERGY SOLUTION, LTD. (KR) | 2023-09-28 | — | — | US | disclosed |
| US-20230307647-A1 | Electrode Active Material for Secondary Battery and Method of Manufacturing Same | LG ENERGY SOLUTION, LTD. (KR) | 2023-09-28 | — | — | US | disclosed |
| US-11220573-B2 | Electrochromic polymers with amide-containing side chains and methods of fabricating same and electrochromic device containing same | AMBILIGHT INC. (US) | 2022-01-11 | — | — | US | disclosed |
| US-20210284790-A1 | PREPARATION METHOD OF POLYMER | LG ENERGY SOLUTION, LTD. (KR) | 2021-09-16 | — | — | US | disclosed |
| US-20210017328-A1 | ELECTROCHROMIC POLYMERS WITH AMIDE-CONTAINING SIDE CHAINS AND METHODS OF FABRICATING SAME AND ELECTROCHROMIC DEVICE CONTAINING SAME | AMBILIGHT INC. | 2021-01-21 | — | — | US | disclosed |
| EP-2402955-B1 | Chemical defunctionalization of polymeric alkylenedioxyheterocyclics - the monomers | UNIV FLORIDA (US) | 2013-07-03 | — | — | EP | disclosed |
| EP-1979916-B1 | CHEMICAL DEFUNCTIONALIZATION OF POLYMERIC ALKYLENEDIOXYHETEROCYCLICS | UNIV FLORIDA (US) | 2012-03-21 | — | — | EP | disclosed |
| EP-2402955-A1 | Chemical defunctionalization of polymeric alkylenedioxyheterocyclics - the monomers | University of Florida Research Foundation, Incorporated (US) | 2012-01-04 | — | — | EP | disclosed |
| US-7807758-B2 | Chemical defunctionalization of polymeric alkylenedioxyheterocyclics | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2010-10-05 | — | — | US | disclosed |
| US-20090221763-A1 | Chemical Defunctionalization of Polymeric Alkylenedioxyheterocyclics | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2009-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090221763-A1 | Chemical Defunctionalization of Polymeric Alkylenedioxyheterocyclics | DDT, STAT3, PTPN22 | EPHX1 2074/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.